Adverse effects: weight gain, increased appetite, fatigue, drowsiness, dizziness, drooling, tremor, constipation. Relapse rates high without medication. Monitor: weight at each visit, CBC, CMP, LFTs and lipid panel on initiation, 3 months after starting, and at least every 6-12 months once stable. TSH as indicated by clinical profile. Prolactin if symptomatic with risperidone